Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
about
Gastrointestinal aspects of vasculitides.Improvement of Arterial Wall Lesions in Parallel with Decrease of Plasma Pentraxin-3 Levels in a Patient with Refractory Takayasu Arteritis after Treatment with TocilizumabTertiary Lymphoid Organs in Takayasu Arteritis.Standard and biological treatment in large vessel vasculitis: guidelines and current approaches.Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis.Treatment of polyarteritis nodosa with tocilizumab: a new therapeutic approach?Takayasu's arteritis: a case with relapse after urgent coronary revascularization.A case report of Takayasu arteritis with aortic dissection as initial presentation.Childhood Takayasu arteritis: disease course and response to therapy.Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).Current and emerging therapies in large-vessel vasculitis.Investigational drugs in systemic vasculitis.A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.Takayasu ArteritisMoving towards new treatments for vasculitisNew Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial TheoryTakayasu's disease effects on the kidneys: current perspectives
P2860
Q30240787-23770F0C-9F01-4271-BF46-2528BECD4E14Q33813735-E867F787-6E8D-47C5-9F25-4D32929C5F63Q36823653-CCD5B0A5-7839-46EC-8953-A9F880668FCAQ39100312-89312064-D000-4F93-B7E2-1D9AA23AF7B2Q39331967-705090EE-8BCF-4EC8-817F-2D71B36D6495Q40353901-0E49BE88-4582-4938-93E8-1A5E9E34B42BQ41544038-E145E7D2-C0C9-4978-802A-6BFE8BF17C98Q41558033-32A99EA5-48E3-4A3B-9F5A-1372F07436D4Q44726623-4AE0931F-ECCD-4201-BDC1-784900FC61FCQ47165426-85A729FA-5A84-48B7-816C-20AD7226AE00Q49388173-E9C96680-FD68-411B-BE0C-E4F11F0FDE1CQ50082820-BA446A56-A843-42A9-AB92-01DB0E2DD20CQ51834131-C298C4A6-7335-477A-A09C-8911EA52C704Q52675492-26872339-F8C8-4F25-B6E5-B428E18471BBQ58552082-6FECB430-566E-4A72-B5EE-2DC163456B79Q58621572-3496B780-6F34-494A-9030-E5FB4F8B6349Q58761058-F9493FD5-A9A2-42B9-8C4F-707892B9D860Q58777758-74E57CCD-BAD3-4FB2-AB91-7F0C4CCF2128
P2860
Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Efficacy of Biological-Targete ...... spective Study of 49 Patients.
@en
Efficacy of Biological-Targete ...... spective Study of 49 Patients.
@nl
type
label
Efficacy of Biological-Targete ...... spective Study of 49 Patients.
@en
Efficacy of Biological-Targete ...... spective Study of 49 Patients.
@nl
prefLabel
Efficacy of Biological-Targete ...... spective Study of 49 Patients.
@en
Efficacy of Biological-Targete ...... spective Study of 49 Patients.
@nl
P2093
P50
P1433
P1476
Efficacy of Biological-Targete ...... spective Study of 49 Patients.
@en
P2093
Arsene Mekinian
Bertrand Godeau
Christian Lavigne
Cloé Comarmond
Emmanuel Messas
French Takayasu Network
Géraldine Muller
Hervé Devilliers
Isabelle Marie
Jean Sibilia
P304
P356
10.1161/CIRCULATIONAHA.114.014321
P407
P50
P577
2015-09-09T00:00:00Z